Cibus (CBUS) and Biographica are pleased to announce a collaborative pilot project focused on advancing disease resistance in oilseed rape and Canola. This partnership leverages Biographica’s proprietary platform to identify and prioritize targets for gene editing, aiming to develop resistance against critical diseases impacting crop health, yield and quality. Under this agreement, Biographica will utilize its cutting-edge AI and machine learning technology to analyze gene targets associated with disease resistance in oilseed rape and Canola and set the stage for future crop improvement strategies.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBUS: